EPHB6 and cancer: Although the actions of some EphB receptors in cancer seem contradictory [11], EphB6 downregulation has been consistently correlated with enhanced aggressiveness and invasiveness in melanoma, neuroblastoma and non–small cell lung cancer [12–15].